Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) Shares Outstanding (Weighted Average) (2016 - 2026)

Skinvisible's Shares Outstanding (Weighted Average) history spans 16 years, with the latest figure at $189000.0 for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 58.19% to $189000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $189000.0, a 58.19% decrease, with the full-year FY2025 number at $189000.0, down 58.19% from a year prior.
  • Shares Outstanding (Weighted Average) hit $189000.0 in Q4 2025 for Skinvisible, down from $5.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for SKVI hit a ceiling of $5.4 million in Q2 2025 and a floor of $60000.0 in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $3.5 million across 5 years, with a median of $4.5 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 7466.41% in 2021 and later crashed 91.98% in 2025.
  • Tracing SKVI's Shares Outstanding (Weighted Average) over 5 years: stood at $4.5 million in 2021, then changed by 0.0% to $4.5 million in 2022, then changed by 0.0% to $4.5 million in 2023, then crashed by 90.04% to $452000.0 in 2024, then crashed by 58.19% to $189000.0 in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for SKVI at $189000.0 in Q4 2025, $5.4 million in Q3 2025, and $5.4 million in Q2 2025.